drug

timwest timwest PRO IBB, D, Long ,
IBB: Biotech's 40% Bear Market is Over
1036 10 34
IBB, D Long
Biotech's 40% Bear Market is Over

There is one useful way to determine when a trend is over and that is using a 50% "speedline" of a move. The decline from $400 in $IBB, the IShares Nasdaq Biotechnology Index Fund back in July 2015 and then tumbled 40% to $240 on February 9th, 2016 and later retested $240 on June 27, 2016. The mid-point of that decline is $320 and a line drawn from ...

tushargupta1991 tushargupta1991 MANGALAM, 60, Long ,
MANGALAM: Mangalam Drugs Long update
18 0 0
MANGALAM, 60 Long
Mangalam Drugs Long update

The wave 2 correction in Mangalam Drugs seems to have become a bit complex. Now it appears to be at a structural support. Also there is 61% Fib support. So it's likely that the up move could start. Any move below wave 1 low would negate this setup.

penniestothousands penniestothousands PRO RXMD, D, Long ,
RXMD: junior drug above cloud 50 200 8ema and weekly cloud
1 0 0
RXMD, D Long
junior drug above cloud 50 200 8ema and weekly cloud

good money flow use limit//stop top of cloud/macd crossed/cci and percent r in upper band/diversify with juniors/enter on good 21 minute bar re fib pullback/adx starting trend/next level 200 weekly.16

penniestothousands penniestothousands PRO ARLZ, D, Long ,
ARLZ: pennies to thousands thinning cloud candidate
14 0 0
ARLZ, D Long
pennies to thousands thinning cloud candidate

j hook pattern see the reason why the shape is important in our book relative strength excellent cci and percent r rising watch 50 day ma

artuncio7 artuncio7 LCI, D, Long ,
LCI: $LCI
25 0 1
LCI, D Long
$LCI

Another drug company, with similar pattern, on strong support. Not playing with this one because overall bearish market conditions in my opinions

DavidSimpson DavidSimpson GILD, D, Long ,
GILD: Gilead ready for Lift-Off Target1: 123.27 Target2: 140 Stop: 93
28 0 0
GILD, D Long
Gilead ready for Lift-Off Target1: 123.27 Target2: 140 Stop: 93

Consistent outperformer with always an Ace up its sleeve. Expect at least a 30% increase in value in 2016. You will never see this stock at these prices ever again. Buy now and thank me Later. All bets are off if we have a financial collapse dragging the share price below 92.96.

RyanMartin RyanMartin HART, 120, Long ,
HART: HART: Going back up so soon?
35 0 2
HART, 120 Long
HART: Going back up so soon?

Harvard Apparatus Regentive Technology is a bioscience company working on more natural heart valve replacements and other pretty cool biotech stuff. However my interest is because the way they are ramping up for another go after moving from $0.60 to $3.25 in less than a month. This is shaping up to be your typical "head and shoulders" scenario. HART's 1day MACD ...

Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
France
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out